Oligonucleotide therapies are among the most promising biological therapeutics. They target disease at a different stage of ...

For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...

Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, ...

OBI-992 is an antibody–drug conjugate (ADC) derived from a novel TROP2-targeted antibody linked to the topoisomerase 1 (TOP1) inhibitor exatecan via an enzyme-cleavable hydrophilic linker, with a drug ...

The purified rabbit pAb were diluted 1:2000 as the primary antibody, and TRITC–conjugated Goat Anti-Rabbit IgG (H + L) (Proteintech, Wuhan, China) was diluted 1:1000 as the secondary antibody for ...

Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal antibodies are derived from hybridoma technology, the recombinant antibodies are ...

A thyroglobulin antibody (TgAb) test looks for certain antibodies that attack the thyroid. The presence of TbAb in high levels may indicate that someone has an autoimmune condition. To conduct a ...

Liquid biopsies broadly refer to the isolation of both cellular and noncellular tumor components including proteins and nucleic acids such as mRNA and circulating free DNA within a liquid sample.

Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a condition of the nervous system that can be managed with lifestyle modifications or medications, depending on your individual needs.

With a strong track record of innovation and quality, GBI supports the development of complex biologics, including monoclonal antibodies, conjugates, and other therapeutic modalities. For more ...

With a strong track record of innovation and quality, GBI supports the development of complex biologics, including monoclonal antibodies, conjugates, and other therapeutic modalities. For more ...